Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) vs National Center for Construction Safety and Health Research and Translation (U54)
Side-by-side comparison of two grants.
| Attribute | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | National Center for Construction Safety and Health Research and Translation (U54) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $5.8M |
| Deadline | Closes 2027-10-15 | Closes 2026-12-01 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | Centers for Disease Control and Prevention - ERA |
| Who it's for | nonprofits, researchers, government | nonprofits, researchers |
noindex — no measured search demand